It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.
This report aims to provide a comprehensive presentation of the global market for Healthcare Nanotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Healthcare Nanotechnology. This report contains market size and forecasts of Healthcare Nanotechnology in global, including the following market information:
- Global Healthcare Nanotechnology Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Healthcare Nanotechnology market was valued at US$ 211810 million in 2022 and is projected to reach US$ 391870 million by 2029, at a CAGR of 9.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The industry is crowded with producers and fierce competition. The U.S. has the highest share of income by region, at more than 48 percent.The key manufacturers are Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith & Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Shire, Ipsen, Endo International etc. Top 3 companies occupied about 2% market share.
We surveyed the Healthcare Nanotechnology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Healthcare Nanotechnology Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Healthcare Nanotechnology Market Segment Percentages, by Type, 2022 (%)
- Nanomedicine
- Nano Medical Devices
- Nano Diagnosis
- Others
Global Healthcare Nanotechnology Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Healthcare Nanotechnology Market Segment Percentages, by Application, 2022 (%)
- Anticancer
- CNS Product
- Anti-infective
- Others
Global Healthcare Nanotechnology Market, BRegion y and Country, 2018-2023, 2024-2029 ($ Millions)
Global Healthcare Nanotechnology Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Healthcare Nanotechnology revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Healthcare Nanotechnology revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Amgen
- Teva Pharmaceuticals
- Abbott
- UCB
- Roche
- Celgene
- Sanofi
- Merck & Co
- Biogen
- Stryker
- Gilead Sciences
- Pfizer
- 3M Company
- Johnson & Johnson
- Smith & Nephew
- Leadiant Biosciences
- Kyowa Hakko Kirin
- Shire
- Ipsen
- Endo International
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Healthcare Nanotechnology, market overview.
- Chapter 2: Global Healthcare Nanotechnology market size in revenue.
- Chapter 3: Detailed analysis of Healthcare Nanotechnology company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Healthcare Nanotechnology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Healthcare Nanotechnology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Healthcare Nanotechnology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Healthcare Nanotechnology Overall Market Size
2.1 Global Healthcare Nanotechnology Market Size: 2022 VS 2029
2.2 Global Healthcare Nanotechnology Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Healthcare Nanotechnology Players in Global Market
3.2 Top Global Healthcare Nanotechnology Companies Ranked by Revenue
3.3 Global Healthcare Nanotechnology Revenue by Companies
3.4 Top 3 and Top 5 Healthcare Nanotechnology Companies in Global Market, by Revenue in 2022
3.5 Global Companies Healthcare Nanotechnology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Healthcare Nanotechnology Players in Global Market
3.6.1 List of Global Tier 1 Healthcare Nanotechnology Companies
3.6.2 List of Global Tier 2 and Tier 3 Healthcare Nanotechnology Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Healthcare Nanotechnology Market Size Markets, 2022 & 2029
4.1.2 Nanomedicine
4.1.3 Nano Medical Devices
4.1.4 Nano Diagnosis
4.1.5 Others
4.2 By Type - Global Healthcare Nanotechnology Revenue & Forecasts
4.2.1 By Type - Global Healthcare Nanotechnology Revenue, 2018-2023
4.2.2 By Type - Global Healthcare Nanotechnology Revenue, 2024-2029
4.2.3 By Type - Global Healthcare Nanotechnology Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Healthcare Nanotechnology Market Size, 2022 & 2029
5.1.2 Anticancer
5.1.3 CNS Product
5.1.4 Anti-infective
5.1.5 Others
5.2 By Application - Global Healthcare Nanotechnology Revenue & Forecasts
5.2.1 By Application - Global Healthcare Nanotechnology Revenue, 2018-2023
5.2.2 By Application - Global Healthcare Nanotechnology Revenue, 2024-2029
5.2.3 By Application - Global Healthcare Nanotechnology Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Healthcare Nanotechnology Market Size, 2022 & 2029
6.2 By Region - Global Healthcare Nanotechnology Revenue & Forecasts
6.2.1 By Region - Global Healthcare Nanotechnology Revenue, 2018-2023
6.2.2 By Region - Global Healthcare Nanotechnology Revenue, 2024-2029
6.2.3 By Region - Global Healthcare Nanotechnology Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Healthcare Nanotechnology Revenue, 2018-2029
6.3.2 US Healthcare Nanotechnology Market Size, 2018-2029
6.3.3 Canada Healthcare Nanotechnology Market Size, 2018-2029
6.3.4 Mexico Healthcare Nanotechnology Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Healthcare Nanotechnology Revenue, 2018-2029
6.4.2 Germany Healthcare Nanotechnology Market Size, 2018-2029
6.4.3 France Healthcare Nanotechnology Market Size, 2018-2029
6.4.4 U.K. Healthcare Nanotechnology Market Size, 2018-2029
6.4.5 Italy Healthcare Nanotechnology Market Size, 2018-2029
6.4.6 Russia Healthcare Nanotechnology Market Size, 2018-2029
6.4.7 Nordic Countries Healthcare Nanotechnology Market Size, 2018-2029
6.4.8 Benelux Healthcare Nanotechnology Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Healthcare Nanotechnology Revenue, 2018-2029
6.5.2 China Healthcare Nanotechnology Market Size, 2018-2029
6.5.3 Japan Healthcare Nanotechnology Market Size, 2018-2029
6.5.4 South Korea Healthcare Nanotechnology Market Size, 2018-2029
6.5.5 Southeast Asia Healthcare Nanotechnology Market Size, 2018-2029
6.5.6 India Healthcare Nanotechnology Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Healthcare Nanotechnology Revenue, 2018-2029
6.6.2 Brazil Healthcare Nanotechnology Market Size, 2018-2029
6.6.3 Argentina Healthcare Nanotechnology Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Healthcare Nanotechnology Revenue, 2018-2029
6.7.2 Turkey Healthcare Nanotechnology Market Size, 2018-2029
6.7.3 Israel Healthcare Nanotechnology Market Size, 2018-2029
6.7.4 Saudi Arabia Healthcare Nanotechnology Market Size, 2018-2029
6.7.5 UAE Healthcare Nanotechnology Market Size, 2018-2029
7 Healthcare Nanotechnology Companies Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Healthcare Nanotechnology Major Product Offerings
7.1.4 Amgen Healthcare Nanotechnology Revenue in Global Market (2018-2023)
7.1.5 Amgen Key News & Latest Developments
7.2 Teva Pharmaceuticals
7.2.1 Teva Pharmaceuticals Company Summary
7.2.2 Teva Pharmaceuticals Business Overview
7.2.3 Teva Pharmaceuticals Healthcare Nanotechnology Major Product Offerings
7.2.4 Teva Pharmaceuticals Healthcare Nanotechnology Revenue in Global Market (2018-2023)
7.2.5 Teva Pharmaceuticals Key News & Latest Developments
7.3 Abbott
7.3.1 Abbott Company Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Healthcare Nanotechnology Major Product Offerings
7.3.4 Abbott Healthcare Nanotechnology Revenue in Global Market (2018-2023)
7.3.5 Abbott Key News & Latest Developments
7.4 UCB
7.4.1 UCB Company Summary
7.4.2 UCB Business Overview
7.4.3 UCB Healthcare Nanotechnology Major Product Offerings
7.4.4 UCB Healthcare Nanotechnology Revenue in Global Market (2018-2023)
7.4.5 UCB Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Healthcare Nanotechnology Major Product Offerings
7.5.4 Roche Healthcare Nanotechnology Revenue in Global Market (2018-2023)
7.5.5 Roche Key News & Latest Developments
7.6 Celgene
7.6.1 Celgene Company Summary
7.6.2 Celgene Business Overview
7.6.3 Celgene Healthcare Nanotechnology Major Product Offerings
7.6.4 Celgene Healthcare Nanotechnology Revenue in Global Market (2018-2023)
7.6.5 Celgene Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Healthcare Nanotechnology Major Product Offerings
7.7.4 Sanofi Healthcare Nanotechnology Revenue in Global Market (2018-2023)
7.7.5 Sanofi Key News & Latest Developments
7.8 Merck & Co
7.8.1 Merck & Co Company Summary
7.8.2 Merck & Co Business Overview
7.8.3 Merck & Co Healthcare Nanotechnology Major Product Offerings
7.8.4 Merck & Co Healthcare Nanotechnology Revenue in Global Market (2018-2023)
7.8.5 Merck & Co Key News & Latest Developments
7.9 Biogen
7.9.1 Biogen Company Summary
7.9.2 Biogen Business Overview
7.9.3 Biogen Healthcare Nanotechnology Major Product Offerings
7.9.4 Biogen Healthcare Nanotechnology Revenue in Global Market (2018-2023)
7.9.5 Biogen Key News & Latest Developments
7.10 Stryker
7.10.1 Stryker Company Summary
7.10.2 Stryker Business Overview
7.10.3 Stryker Healthcare Nanotechnology Major Product Offerings
7.10.4 Stryker Healthcare Nanotechnology Revenue in Global Market (2018-2023)
7.10.5 Stryker Key News & Latest Developments
7.11 Gilead Sciences
7.11.1 Gilead Sciences Company Summary
7.11.2 Gilead Sciences Business Overview
7.11.3 Gilead Sciences Healthcare Nanotechnology Major Product Offerings
7.11.4 Gilead Sciences Healthcare Nanotechnology Revenue in Global Market (2018-2023)
7.11.5 Gilead Sciences Key News & Latest Developments
7.12 Pfizer
7.12.1 Pfizer Company Summary
7.12.2 Pfizer Business Overview
7.12.3 Pfizer Healthcare Nanotechnology Major Product Offerings
7.12.4 Pfizer Healthcare Nanotechnology Revenue in Global Market (2018-2023)
7.12.5 Pfizer Key News & Latest Developments
7.13 3M Company
7.13.1 3M Company Company Summary
7.13.2 3M Company Business Overview
7.13.3 3M Company Healthcare Nanotechnology Major Product Offerings
7.13.4 3M Company Healthcare Nanotechnology Revenue in Global Market (2018-2023)
7.13.5 3M Company Key News & Latest Developments
7.14 Johnson & Johnson
7.14.1 Johnson & Johnson Company Summary
7.14.2 Johnson & Johnson Business Overview
7.14.3 Johnson & Johnson Healthcare Nanotechnology Major Product Offerings
7.14.4 Johnson & Johnson Healthcare Nanotechnology Revenue in Global Market (2018-2023)
7.14.5 Johnson & Johnson Key News & Latest Developments
7.15 Smith & Nephew
7.15.1 Smith & Nephew Company Summary
7.15.2 Smith & Nephew Business Overview
7.15.3 Smith & Nephew Healthcare Nanotechnology Major Product Offerings
7.15.4 Smith & Nephew Healthcare Nanotechnology Revenue in Global Market (2018-2023)
7.15.5 Smith & Nephew Key News & Latest Developments
7.16 Leadiant Biosciences
7.16.1 Leadiant Biosciences Company Summary
7.16.2 Leadiant Biosciences Business Overview
7.16.3 Leadiant Biosciences Healthcare Nanotechnology Major Product Offerings
7.16.4 Leadiant Biosciences Healthcare Nanotechnology Revenue in Global Market (2018-2023)
7.16.5 Leadiant Biosciences Key News & Latest Developments
7.17 Kyowa Hakko Kirin
7.17.1 Kyowa Hakko Kirin Company Summary
7.17.2 Kyowa Hakko Kirin Business Overview
7.17.3 Kyowa Hakko Kirin Healthcare Nanotechnology Major Product Offerings
7.17.4 Kyowa Hakko Kirin Healthcare Nanotechnology Revenue in Global Market (2018-2023)
7.17.5 Kyowa Hakko Kirin Key News & Latest Developments
7.18 Shire
7.18.1 Shire Company Summary
7.18.2 Shire Business Overview
7.18.3 Shire Healthcare Nanotechnology Major Product Offerings
7.18.4 Shire Healthcare Nanotechnology Revenue in Global Market (2018-2023)
7.18.5 Shire Key News & Latest Developments
7.19 Ipsen
7.19.1 Ipsen Company Summary
7.19.2 Ipsen Business Overview
7.19.3 Ipsen Healthcare Nanotechnology Major Product Offerings
7.19.4 Ipsen Healthcare Nanotechnology Revenue in Global Market (2018-2023)
7.19.5 Ipsen Key News & Latest Developments
7.20 Endo International
7.20.1 Endo International Company Summary
7.20.2 Endo International Business Overview
7.20.3 Endo International Healthcare Nanotechnology Major Product Offerings
7.20.4 Endo International Healthcare Nanotechnology Revenue in Global Market (2018-2023)
7.20.5 Endo International Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Healthcare Nanotechnology Market Opportunities & Trends in Global Market
Table 2. Healthcare Nanotechnology Market Drivers in Global Market
Table 3. Healthcare Nanotechnology Market Restraints in Global Market
Table 4. Key Players of Healthcare Nanotechnology in Global Market
Table 5. Top Healthcare Nanotechnology Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Healthcare Nanotechnology Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Healthcare Nanotechnology Revenue Share by Companies, 2018-2023
Table 8. Global Companies Healthcare Nanotechnology Product Type
Table 9. List of Global Tier 1 Healthcare Nanotechnology Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Healthcare Nanotechnology Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Healthcare Nanotechnology Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Healthcare Nanotechnology Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Healthcare Nanotechnology Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Healthcare Nanotechnology Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Healthcare Nanotechnology Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Healthcare Nanotechnology Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Healthcare Nanotechnology Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Healthcare Nanotechnology Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Healthcare Nanotechnology Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Healthcare Nanotechnology Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Healthcare Nanotechnology Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Healthcare Nanotechnology Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Healthcare Nanotechnology Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Healthcare Nanotechnology Revenue, (US$, Mn), 2024-2029
Table 30. Amgen Company Summary
Table 31. Amgen Healthcare Nanotechnology Product Offerings
Table 32. Amgen Healthcare Nanotechnology Revenue (US$, Mn) & (2018-2023)
Table 33. Amgen Key News & Latest Developments
Table 34. Teva Pharmaceuticals Company Summary
Table 35. Teva Pharmaceuticals Healthcare Nanotechnology Product Offerings
Table 36. Teva Pharmaceuticals Healthcare Nanotechnology Revenue (US$, Mn) & (2018-2023)
Table 37. Teva Pharmaceuticals Key News & Latest Developments
Table 38. Abbott Company Summary
Table 39. Abbott Healthcare Nanotechnology Product Offerings
Table 40. Abbott Healthcare Nanotechnology Revenue (US$, Mn) & (2018-2023)
Table 41. Abbott Key News & Latest Developments
Table 42. UCB Company Summary
Table 43. UCB Healthcare Nanotechnology Product Offerings
Table 44. UCB Healthcare Nanotechnology Revenue (US$, Mn) & (2018-2023)
Table 45. UCB Key News & Latest Developments
Table 46. Roche Company Summary
Table 47. Roche Healthcare Nanotechnology Product Offerings
Table 48. Roche Healthcare Nanotechnology Revenue (US$, Mn) & (2018-2023)
Table 49. Roche Key News & Latest Developments
Table 50. Celgene Company Summary
Table 51. Celgene Healthcare Nanotechnology Product Offerings
Table 52. Celgene Healthcare Nanotechnology Revenue (US$, Mn) & (2018-2023)
Table 53. Celgene Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Healthcare Nanotechnology Product Offerings
Table 56. Sanofi Healthcare Nanotechnology Revenue (US$, Mn) & (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Merck & Co Company Summary
Table 59. Merck & Co Healthcare Nanotechnology Product Offerings
Table 60. Merck & Co Healthcare Nanotechnology Revenue (US$, Mn) & (2018-2023)
Table 61. Merck & Co Key News & Latest Developments
Table 62. Biogen Company Summary
Table 63. Biogen Healthcare Nanotechnology Product Offerings
Table 64. Biogen Healthcare Nanotechnology Revenue (US$, Mn) & (2018-2023)
Table 65. Biogen Key News & Latest Developments
Table 66. Stryker Company Summary
Table 67. Stryker Healthcare Nanotechnology Product Offerings
Table 68. Stryker Healthcare Nanotechnology Revenue (US$, Mn) & (2018-2023)
Table 69. Stryker Key News & Latest Developments
Table 70. Gilead Sciences Company Summary
Table 71. Gilead Sciences Healthcare Nanotechnology Product Offerings
Table 72. Gilead Sciences Healthcare Nanotechnology Revenue (US$, Mn) & (2018-2023)
Table 73. Gilead Sciences Key News & Latest Developments
Table 74. Pfizer Company Summary
Table 75. Pfizer Healthcare Nanotechnology Product Offerings
Table 76. Pfizer Healthcare Nanotechnology Revenue (US$, Mn) & (2018-2023)
Table 77. Pfizer Key News & Latest Developments
Table 78. 3M Company Company Summary
Table 79. 3M Company Healthcare Nanotechnology Product Offerings
Table 80. 3M Company Healthcare Nanotechnology Revenue (US$, Mn) & (2018-2023)
Table 81. 3M Company Key News & Latest Developments
Table 82. Johnson & Johnson Company Summary
Table 83. Johnson & Johnson Healthcare Nanotechnology Product Offerings
Table 84. Johnson & Johnson Healthcare Nanotechnology Revenue (US$, Mn) & (2018-2023)
Table 85. Johnson & Johnson Key News & Latest Developments
Table 86. Smith & Nephew Company Summary
Table 87. Smith & Nephew Healthcare Nanotechnology Product Offerings
Table 88. Smith & Nephew Healthcare Nanotechnology Revenue (US$, Mn) & (2018-2023)
Table 89. Smith & Nephew Key News & Latest Developments
Table 90. Leadiant Biosciences Company Summary
Table 91. Leadiant Biosciences Healthcare Nanotechnology Product Offerings
Table 92. Leadiant Biosciences Healthcare Nanotechnology Revenue (US$, Mn) & (2018-2023)
Table 93. Leadiant Biosciences Key News & Latest Developments
Table 94. Kyowa Hakko Kirin Company Summary
Table 95. Kyowa Hakko Kirin Healthcare Nanotechnology Product Offerings
Table 96. Kyowa Hakko Kirin Healthcare Nanotechnology Revenue (US$, Mn) & (2018-2023)
Table 97. Kyowa Hakko Kirin Key News & Latest Developments
Table 98. Shire Company Summary
Table 99. Shire Healthcare Nanotechnology Product Offerings
Table 100. Shire Healthcare Nanotechnology Revenue (US$, Mn) & (2018-2023)
Table 101. Shire Key News & Latest Developments
Table 102. Ipsen Company Summary
Table 103. Ipsen Healthcare Nanotechnology Product Offerings
Table 104. Ipsen Healthcare Nanotechnology Revenue (US$, Mn) & (2018-2023)
Table 105. Ipsen Key News & Latest Developments
Table 106. Endo International Company Summary
Table 107. Endo International Healthcare Nanotechnology Product Offerings
Table 108. Endo International Healthcare Nanotechnology Revenue (US$, Mn) & (2018-2023)
Table 109. Endo International Key News & Latest Developments
List of Figures
Figure 1. Healthcare Nanotechnology Segment by Type in 2022
Figure 2. Healthcare Nanotechnology Segment by Application in 2022
Figure 3. Global Healthcare Nanotechnology Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Healthcare Nanotechnology Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Healthcare Nanotechnology Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Healthcare Nanotechnology Revenue in 2022
Figure 8. By Type - Global Healthcare Nanotechnology Revenue Market Share, 2018-2029
Figure 9. By Application - Global Healthcare Nanotechnology Revenue Market Share, 2018-2029
Figure 10. By Type - Global Healthcare Nanotechnology Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Healthcare Nanotechnology Revenue Market Share, 2018-2029
Figure 12. By Application - Global Healthcare Nanotechnology Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Healthcare Nanotechnology Revenue Market Share, 2018-2029
Figure 14. By Region - Global Healthcare Nanotechnology Revenue Market Share, 2018-2029
Figure 15. By Country - North America Healthcare Nanotechnology Revenue Market Share, 2018-2029
Figure 16. US Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Healthcare Nanotechnology Revenue Market Share, 2018-2029
Figure 20. Germany Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2029
Figure 21. France Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Healthcare Nanotechnology Revenue Market Share, 2018-2029
Figure 28. China Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2029
Figure 32. India Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Healthcare Nanotechnology Revenue Market Share, 2018-2029
Figure 34. Brazil Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Healthcare Nanotechnology Revenue Market Share, 2018-2029
Figure 37. Turkey Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Healthcare Nanotechnology Revenue, (US$, Mn), 2018-2029
Figure 41. Amgen Healthcare Nanotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Teva Pharmaceuticals Healthcare Nanotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Abbott Healthcare Nanotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. UCB Healthcare Nanotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Roche Healthcare Nanotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Celgene Healthcare Nanotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sanofi Healthcare Nanotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Merck & Co Healthcare Nanotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Biogen Healthcare Nanotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Stryker Healthcare Nanotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Gilead Sciences Healthcare Nanotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Pfizer Healthcare Nanotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. 3M Company Healthcare Nanotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Johnson & Johnson Healthcare Nanotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Smith & Nephew Healthcare Nanotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Leadiant Biosciences Healthcare Nanotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Kyowa Hakko Kirin Healthcare Nanotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Shire Healthcare Nanotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Ipsen Healthcare Nanotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Endo International Healthcare Nanotechnology Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
